TUESDAY, Oct. 27, 2020 -- Testing of Eli Lilly's antibody drug for hospitalized COVID-19 patients has been halted because the treatment doesn't help them recover from their infection.
Two weeks ago, enrollment in the study was paused because of a possible safety issue, the Associated Press reported. But the U.S. National Institute of Allergy and Infectious Diseases, which sponsored the Lilly study, pulled the plug on the trial Monday -- not because of any safety problem, but because there was only a slight chance that the drug would be effective, the AP said.
TUESDAY, Oct. 27, 2020 -- Stuck at home, bored. Fiddling with their phone or playing video games. Munching on snack foods to while away the time.
School-age children gaining excess pounds could be one lasting health problem caused by the COVID-19 pandemic, with pediatricians and public health experts warning about a potentially dramatic increase in childhood obesity.
TUESDAY, Oct. 27, 2020 -- Replacing sugary drinks with diet versions may not be any healthier for the heart, a large, new study suggests.
French researchers found that people who regularly drank artificially sweetened beverages had a higher risk of heart disease and stroke, versus people who avoided those beverages. In fact, they were no less likely to develop cardiovascular disease than people who regularly downed sugary drinks.
TUESDAY, Oct. 27, 2020 -- Researchers in the United Kingdom have reassuring news for people with psoriasis based on the first analysis of a global registry of COVID-19 patients who also have the skin disease.
Moderate-to-severe cases of psoriasis are treated with drugs that suppress the immune system. This analysis of the international PsoProtect registry found that more than 90% of psoriasis patients survive infection with the new coronavirus.
TUESDAY, Oct. 27, 2020 -- When adults with Down syndrome contract COVID-19, their risk of dying is much higher than the norm, a large, new study finds.
The researchers found that of over 8 million British adults, those with Down syndrome were four times more likely to be hospitalized with COVID-19, and 10 times more likely to die due to the infection.